BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33022479
Number of visits today
5469
Number of downloads
16211927
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Xie Y, Long Q, Wu Q, Shi S, Dai M, Liu Y, Liu L, Gong C, Qian Z, Wei Y, Zhao X. Improving therapeutic effect in ovarian peritoneal carcinomatosis with honokiol nanoparticles in a thermosensitive hydrogel composite. RSC Adv 2012;2:7759. [DOI: 10.1039/c2ra20612a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Seguin J, Pimpie C, Roy P, Al Sabbagh C, Pocard M, Mignet N, Boudy V. Combination of tumor cell anti-adhesion and anti-tumor effect to prevent recurrence after cytoreductive surgery in a mice model. Eur J Pharm Biopharm 2021:S0939-6411(21)00038-2. [PMID: 33727143 DOI: 10.1016/j.ejpb.2021.01.020] [Reference Citation Analysis]
2 Miller EM, Samec TM, Alexander-Bryant AA. Nanoparticle delivery systems to combat drug resistance in ovarian cancer. Nanomedicine 2021;31:102309. [PMID: 32992019 DOI: 10.1016/j.nano.2020.102309] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
3 Padmakumar S, Parayath N, Leslie F, Nair SV, Menon D, Amiji MM. Intraperitoneal chemotherapy for ovarian cancer using sustained-release implantable devices. Expert Opin Drug Deliv 2018;15:481-94. [PMID: 29488406 DOI: 10.1080/17425247.2018.1446938] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
4 Song Z, Sun J, Deng P, Zhou F, Xu H, Wen Y, Teng F, Ge D, Feng R. Oligochitosan-pluronic 127 conjugate for delivery of honokiol. Artificial Cells, Nanomedicine, and Biotechnology 2018;46:740-50. [DOI: 10.1080/21691401.2018.1434785] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
5 Cheng Y, Zheng S, Teng Y, Muftuoglu Y, Zhao C, Chen S, Gao X, You C. Preparation of honokiol with biodegradable nanoparticles for treatment of osteosarcoma. RSC Adv 2016;6:94278-86. [DOI: 10.1039/c6ra21479g] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
6 Wacker KT, Kristufek SL, Lim S, Kahn S, Wooley KL. Bio-based polycarbonates derived from the neolignan honokiol. RSC Adv 2016;6:81672-9. [DOI: 10.1039/c6ra19568g] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345